Loading stock data…
Loading stock data…
US$2.44
Get one email when VERU crosses your level. Checked every 15 minutes during market hours.
▲ +0.09 (3.83%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
41.0
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.11
Bearish momentumMACD below its signal line (-0.02).
50-day average
2.67
Price belowShort-term trend reference.
200-day average
2.66
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Veru Inc. is a biopharmaceutical company focused on developing and commercializing novel small‑molecule therapies for cardiometabolic and inflammatory diseases. The company’s lead program centers on enobosarm, an oral selective androgen receptor modulator being evaluated to mitigate loss of muscle mass and function in patients undergoing weight loss treatment with GLP‑1–based therapies, aiming to support higher-quality weight reduction by preserving lean tissue. Veru Inc. is also advancing sabiz…
verupharma.com3 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-07-01)
3 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-06-01)
3 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-05-01)
3 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-13 | -0.28 | -0.13 | ✓ Beat |
| 2026-03-27 | -3.78 | -0.97 | ✓ Beat |
| 2026-03-13 | 0.05 | 0.07 | ✓ Beat |
| 2026-02-11 | -0.47 | -0.26 | ✓ Beat |
| 2025-12-17 | -0.39 | 0.09 | ✓ Beat |
| 2025-08-12 | -0.5 | -0.53 | ✗ Miss |
| 2025-05-08 | -0.5 | -0.6 | ✗ Miss |
Companies in the same industry, via Finnhub